Mechanism and Research Interest

Primary Biological Pathway: Neurotrophin Upregulation

The core research interest in Semax lies in its ability to rapidly stimulate the expression of neurotrophins in the hippocampus and basal forebrain.

Specifically, Semax has been observed to upregulate Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) by up to 500% in rodent models. These proteins are the architects of neuroplasticity, governing the survival of existing neurons and the growth of new synaptic connections (synaptogenesis). The 10mg pen allows researchers to investigate the dose-dependent kinetics of this upregulation, specifically testing the hypothesis that Semax triggers the TrkB receptor signalling cascade to enhance long-term potentiation (LTP).

Secondary Research Finding: Ischaemic Neuroprotection

Semax was originally developed to treat ischaemic stroke, and it remains a critical tool for researching cerebral hypoxia. Studies demonstrate that the peptide exerts a profound cytoprotective effect during oxidative stress. By inhibiting the expression of genes involved in inflammation and apoptosis, Semax preserves tissue viability in the “penumbra” (the salvageable tissue surrounding an infarct). Researchers utilise the 10mg format to deliver high-dose boluses in animal models of Middle Cerebral Artery Occlusion (MCAO), measuring the reduction in infarct volume and neurological deficit scores.

Tertiary Research Finding: Dopaminergic and Serotonergic Modulation

Beyond structural repair, Semax influences the neurochemical landscape of the brain. It acts as a modulator of the dopaminergic and serotonergic systems, which are central to attention, motivation, and mood. Unlike amphetamines which force the release of catecholamines (leading to depletion), Semax appears to optimise the turnover rate and receptor sensitivity of these neurotransmitters. This mechanism is currently being researched in models of Attention Deficit Hyperactivity Disorder (ADHD), where the goal is to improve executive function without inducing psychomotor agitation.

Long-term Genomic and Safety Observations

A key safety advantage of Semax is its lack of corticotropic activity. Despite being an ACTH fragment, it does not stimulate the adrenal glands to produce cortisol. Genomic studies using the 10mg dosage are currently profiling the transcriptome of the striatum to confirm that chronic administration enhances cognitive markers (c-Fos expression) without dysregulating the HPA axis or inducing the transcriptional signatures of chronic stress.

Product Specifications

• Purity: Validated at >98+% via High-Performance Liquid Chromatography (HPLC). The presence of the Methionine residue is confirmed, and the peptide is free from truncated ACTH fragments.

• Appearance: The 3ml pen contains a clear, colourless, sterile liquid.

• Precision: The pen delivery system allows for the administration of precise micro-volumes. This is essential for intranasal delivery simulations or stereotaxic injections where volume accuracy is critical.

• Storage: The product must be stored at 2∘C to 8∘𝐶.

Storage and Shipping Guidelines

Refrigeration and Shelf Life

The Semax 10mg Pen is a stable peptide due to its Pro-Gly-Pro tail, but it still requires refrigeration ($2^{\circ}C$ to $8^{\circ}C$) to maintain maximum potency over time. The shelf life is 12 months in the sealed state. Once the pen is accessed, the bacteriostatic environment preserves the solution for 28 days. Researchers should be aware that while the PGP tail protects against rapid degradation, exposure to heat can still denature the methionine residue, reducing efficacy.

Shipping Stability

We utilise medical-grade thermal packaging. The peptide is stable for up to 72 hours at ambient UK temperatures. However, to ensure the neurotrophic potential is fully preserved, we recommend selecting the fastest available shipping option.

Freezing Warning

Do not freeze. Freezing the solution can induce aggregation of the peptide molecules. Upon thawing, the solution may become non-homogenous. In neuro-sensitive assays, administering aggregated peptide can lead to inconsistent absorption rates and variable BDNF responses. A frozen pen should be discarded.

Why Choose the Peptide Pro 3ml Pen Format?

The Semax 10mg Pen is the definitive tool for Cognitive and Neuroprotection Research.

In cognitive behavioural assays (such as the Morris Water Maze), the stress of administration can mask the nootropic effects of the compound. Manual injections are often invasive and variable.

Our precision pen format ensures consistent, sterile delivery with minimal handling time. This reliability is paramount when trying to detect subtle improvements in learning curves or memory retention rates.

For researchers investigating related anxiolytic or neuro-restorative pathways, we recommend examining:

• Selank 10mg:  (For comparative studies on Tuftsin-derived anxiolytics).

• VIP 10mg: (For research into neuro-circadian regulation).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection, therapeutic use (e.g., for stroke recovery or ADHD treatment), or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.